article thumbnail

Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding Risk

DAIC

In addition, abelacimab consistently reduced bleeding risk in patients 75 years of age and older regardless of renal function, body mass index (BMI), and the use of concomitant antiplatelet therapy. 2021 3 Hsu et al. 2021 4 Hsu et al. 2021 5 TIMI Study Group website , AZALEA 71 6 Yi BA et al. 2021 7 Ruff C et al.

article thumbnail

Global Burden of Disease Study Details Ballooning Prevalence of Metabolic Risk Factors

HCPLive

Increases in metabolic risk factors like high blood pressure and BMI have led to a 49.4% increase in global disability-adjusted life years from 2000 to 2021.

article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

Excess weight, as measured by BMI, is typically considered a measure of excess body fat. When someone is classified as being of ‘normal’ weight, that typically means they have a BMI of less than 25. The relationship between excess weight, a high BMI and the risk of severe insulin resistance and diabetes is clear 4.

article thumbnail

Relationship between epicardial adipose tissue volume and atrial fibrillation in patients with rheumatoid arthritis

Frontiers in Cardiovascular Medicine

In addition, the risks of stroke and bleeding in patients with both RA and AF are unknown.MethodsA retrospective analysis was conducted in patients with RA aged 18years from August 2021 to May 2023, and compared with age- and gender-matched patients without RA.

article thumbnail

Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

European Journal of Heart Failure

BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. Methods and results Patients with HFrEF enrolled in the Swedish Heart Failure Registry between 2006 and 2021 were linked to the Prescribed Drug Register.

article thumbnail

Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week

Cardiometabolic Health Congress

Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension. Among these options is semaglutide (Wegovy), a medication that has gained attention for its effectiveness in aiding weight loss efforts.

Obesity 97
article thumbnail

Abstract WP203: Ipsilateral Hemodynamic Failure of Extracranial Internal Carotid Artery is Associated with Severe Middle Cerebral Artery Atherosclerosis——a 4D Flow MRI Study

Stroke Journal

We aimed to investigate associations between the hemodynamics of internal carotid artery (ICA) and ipsilateral MCA atherosclerosis.Methods:Patients diagnosed with unilateral MCA atherosclerosis by computed tomography angiography were enrolled from July 2021 to June 2024. MR system equipped with a 16-channel head-neck coil for all patients.